These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase. Tobin T; Akera T; Ku D; Lu MC Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674 [No Abstract] [Full Text] [Related]
7. Dissociation of the positive inotropic action of digitalis from inhibition of sodium- and potassium-activated adenosine triphosphate. Okita GT; Richardson F; Roth-Schechter BF J Pharmacol Exp Ther; 1973 Apr; 185(1):1-11. PubMed ID: 4266379 [No Abstract] [Full Text] [Related]
8. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate. Yoda A; Yoda S Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671 [No Abstract] [Full Text] [Related]
9. Cardiotonic steroids. I. Importance of 14 beta-hydroxy group in digitoxigenin. Naidoo BK; Witty TR; Remers WA; Besch HR J Pharm Sci; 1974 Sep; 63(9):1391-4. PubMed ID: 4279284 [No Abstract] [Full Text] [Related]
10. Rates of dissociation of enzyme-ouabain complexes and K 0.5 values in (Na + + K + ) adenosine triphosphatase from different species. Tobin T; Brody TM Biochem Pharmacol; 1972 Jun; 21(11):1553-60. PubMed ID: 4265025 [No Abstract] [Full Text] [Related]
11. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by cardenolide alkylating agents. Abramson HN; Cho JS J Med Chem; 1971 Jun; 14(6):509-11. PubMed ID: 4253727 [No Abstract] [Full Text] [Related]
12. On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain. Yoda A; Hokin LE Biochem Biophys Res Commun; 1970 Aug; 40(4):880-6. PubMed ID: 4251204 [No Abstract] [Full Text] [Related]
13. [Biochemical aspects of digitalis therapy]. Repke KR Z Gesamte Inn Med; 1971 Feb; 26(3):Suppl:8-16. PubMed ID: 4254384 [No Abstract] [Full Text] [Related]
14. Cardenolide analogues. 4. (20R)- and (20S)-Cardanolides: on the roles of the 20(22)-ene and 14beta-hydroxyl in genin activity. Fullerton DS; Yoshioka K; Rohrer DC; From AH; Ahmed K J Med Chem; 1979 May; 22(5):529-33. PubMed ID: 222907 [TBL] [Abstract][Full Text] [Related]
15. Relationship between the potentiation of potassium-induced contracture of cardiac muscle by four cardenolides and their inhibitory effects on the sodium potassium activated adenosine triphosphatase of brain. Shigei T; Takeda K; Tashima Y; Nakao M Experientia; 1971 Apr; 27(4):415-6. PubMed ID: 4253047 [No Abstract] [Full Text] [Related]
16. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate. Yoda A Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446 [No Abstract] [Full Text] [Related]
17. The nature of the transport adenosine triphosphatase-digitalis complex. VII. Characteristics of ouabagenin-Na+,K+-adenosine triphosphatase interaction. Wallick ET; Dowd F; Allen JC; Schwartz A J Pharmacol Exp Ther; 1974 May; 189(2):434-44. PubMed ID: 4275234 [No Abstract] [Full Text] [Related]
18. Effect of monovalent cations on the ouabain iniibition of the sodium and potassium ion activated adenosine triphosphatase. Barnett RE Biochemistry; 1970 Nov; 9(24):4644-8. PubMed ID: 4249365 [No Abstract] [Full Text] [Related]
19. An allosteric explanation for ouabain-induced time-dependent inhibition of sodium, potassium-adenosine triphosphatase. Allen JC; Lindenmayer GE; Schwartz A Arch Biochem Biophys; 1970 Nov; 141(1):322-8. PubMed ID: 4249246 [No Abstract] [Full Text] [Related]
20. Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase. Albers RW; Koval GJ; Siegel Mol Pharmacol; 1968 Jul; 4(4):324-36. PubMed ID: 4232893 [No Abstract] [Full Text] [Related] [Next] [New Search]